This site uses cookies to improve your experience.

We use necessary cookies to make our site work. We would also like to set optional analytics cookies to help us improve our site by anonymously collecting and reporting information on how you use it. For more information on how these cookies work, please see our Cookie Policy.

10
Goodbye, for now.
  • Portfolio
  • Team
  • Sōzō Insights
  • Work With Us
Toggle Menu
  • Portfolio
  • Team
  • Sōzō Insights
  • Work With Us
  • SoftBank Careers
  • Terms
    © 2024 SB Investment Advisers (UK) Limited
    SoftBank Vision Fund Asset
    Q&A

    Elad Walach: Using AI in medical imaging is transforming patient care

    How a devotion to accuracy helped Aidoc create a foundation model from the ground up

    The Silicon Valley mantra of move fast and break things doesn’t work in healthcare — not when what you might break is a human life.Elad Walach, Co-founder & CEO, Aidoc

    What kind of impact does aiOS have on patient care?

    Imaging backlogs across the U.S. mean it can take weeks to get results. If something serious is hiding in the data, you shouldn’t have to wait. For example, around 2% of cancer patients have pulmonary embolisms that need to be flagged immediately. In rural emergency rooms, it can take two hours to get scan results. If you have a brain bleed, two hours is too long. With strokes, every 60 seconds of delay can cost a patient nearly two million brain cells.

    Instead of reading scans in the order they arrive, Aidoc flags critical findings — brain bleeds, pulmonary emboli, air in the chest and abdomen — almost instantly. AI isn’t making the diagnosis; it’s giving the doctors the information they need to look at a case, confirm what’s happening, and act quickly. It’s a whole new way of working. You’re no longer waiting on an overstretched radiologist to get to your scan.

    Healthcare today puts enormous stress on providers and creates delays for patients. AI can help alleviate a lot of that.Elad Walach, Co-founder & CEO, Aidoc

    What’s surprised you most about Aidoc’s journey?

    How bad healthcare’s last mile problem is — in other words, the gap between jaw-dropping demos and real-world deployment. It’s 10 times worse than most industries. Interoperability is difficult; safety constraints are very demanding. So we’ve had to think carefully about how to implement AI in ways that clinicians actually want to use. That’s why our platform is vendor-neutral, customizable to our customers’ existing IT stacks, and designed to run in any clinical setting while orchestrating numerous AI applications at once.

    The mistake many innovators make is assuming they’re bringing fully-formed solutions into the world. We can bring a lot of the technology, but need leaders and evangelists inside health systems — whether that’s a CEO or innovative radiologist — who genuinely want to integrate these tools into their workflows and transform how care is delivered. If you don’t have partners to work with on implementation, you’re just going to get fancy technology on a broken workflow. 

    Today, our platform is used by cardiologists, neurosurgeons, and ER physicians, not just radiologists. Radiology is still in the center, but this is a health system transformation.

    Next
    FeatureReimagining the road to self-driving cars

    Wayve challenges Silicon Valley with a contrarian bet on autonomy

    Results of Chief Human Resources Officers (CHRO) state of the industry in 2026 survey by SoftBank Vision Fund.
    Sōzō PulseExplore exclusive survey data

    Track trends over time — filter by region, sector, and stage

    SoftBank Vision Fund's Sōzō Insights from our ecosystem logo
    Sign up for our newsletter
    Stay up to date with the latest data and insights
    • Portfolio
    • Team
    • Sōzō Insights
      • All Insights
      • Sōzō Pulse
      • About Sōzō
      • Newsletter Signup
    • Work With Us
    • Portfolio Careers
    • Company
      • Sustainability
      • Presentations
    • Contact
    • Terms
    • |
    • Privacy
    • |
    • Regulatory
    • |
    © 2026 SB Investment Advisers (UK) Limited